1 Department of Radiology, Hangzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China 2 Department of Radiology, Ningbo Yinzhou No. 2.
2 Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Düsseldorf, Germany Introduction Prostate cancer (PCa) is the second most common cancer ...
Alam frames PHI and MRI as noninvasive tools that help refine risk before proceeding to biopsy. In this video, Ridwan I. Alam, MD, MPH, discusses how the Prostate Health Index (PHI) performs alongside ...
ABSTRACT: Introduction: Prostate cancer (PC) is a malignant proliferation of prostate cells. Common screening methods, such as digital rectal examination and prostate-specific antigen (PSA) testing, ...
Objective: This study aimed to investigate independent risk factors for clinically significant prostate cancer (csPCa) using serologic indices, multiparametric magnetic resonance imaging (mpMRI), and ...
Purpose: The accurate diagnosis of prostate cancer (PCa) remains challenging, particularly because standard biopsy techniques do not routinely include anterior zone, leading to potential missed ...
Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...
Chatterjee A, Yousuf AN, Engelmann R, et al. Prospective validation of an automated hybrid multidimensional MRI tool for prostate cancer detection using targeted biopsy: Comparison with PI-RADS-based ...
Dr. Aytekin Oto discussed Prostate MRI 101, noting that prostate MRI has evolved significantly since its first publication in 1982, with multiparametric MRI now embraced worldwide. With regards to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results